SO
STOK icon

STRS Ohio’s Stoke Therapeutics STOK Stock Holding History

STRS Ohio’s Portfolio STOK Stock Details STOK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-7,000
Closed -$228K – 2316
2026
Q1 		$228K Hold
7,000
– – ﹤0.01% 1441
2025
Q4 		$222K Buy
7,000
+600
+9% +$18K ﹤0.01% 1477
2025
Q3 		$150K Buy
+6,400
New +$110K ﹤0.01% 1675
2025
Q1 		– Sell
-3,800
Closed -$41.9K – 2013
2024
Q4 		$41.9K Buy
3,800
+1,500
+65% +$18.4K ﹤0.01% 1747
2024
Q3 		$28.3K Hold
2,300
– – ﹤0.01% 1871
2024
Q2 		$31.1K Buy
+2,300
New +$31.1K ﹤0.01% 1846
2022
Q2 		– Sell
-3,500
Closed -$73K – 2276
2022
Q1 		$73K Hold
3,500
– – ﹤0.01% 1899
2021
Q4 		$83K Hold
3,500
– – ﹤0.01% 1934
2021
Q3 		$89K Hold
3,500
– – ﹤0.01% 1967
2021
Q2 		$117K Buy
3,500
+300
+9% +$10.6K ﹤0.01% 1942
2021
Q1 		$124K Buy
3,200
+3,100
+3,100% +$176K ﹤0.01% 1905
2020
Q4 		$6K Hold
100
– – ﹤0.01% 2125
2020
Q3 		$3K Sell
100
-2,300
-96% -$65.7K ﹤0.01% 2167
2020
Q2 		$57K Hold
2,400
– – ﹤0.01% 1889
2020
Q1 		$54K Hold
2,400
– – ﹤0.01% 1774
2019
Q4 		$67K Hold
2,400
– – ﹤0.01% 1847
2019
Q3 		$51K Buy
+2,400
New +$66.9K ﹤0.01% 1877

Other funds holding STOK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

STRS Ohio's STOK Position: Q2 2026 in Review

STRS Ohio sold out of Stoke Therapeutics (STOK) in Q2 2026, closing a stake of 7,000 shares — an estimated $228K sold.

STRS Ohio first reported a position in STOK in Q3 2019 and held it in 17 quarters. The position peaked at $228K in Q1 2026. 197 funds tracked by Wall St. Rank hold STOK as of Q2 2026.

  • STRS Ohio reported no remaining Stoke Therapeutics position as of Q2 2026 after selling out during the quarter.
  • STRS Ohio sold 7,000 Stoke Therapeutics shares in Q2 2026, an estimated $228K.
  • STRS Ohio first reported a position in Stoke Therapeutics in Q3 2019 and held it in 17 quarters.
  • STRS Ohio's Stoke Therapeutics position peaked at $228K in Q1 2026.
  • 197 funds tracked by Wall St. Rank held Stoke Therapeutics as of Q2 2026.

Based on STRS Ohio's 13F filing for Q2 2026, filed 30 Jul 2026.